Stryker Corp Boosts Sales 11.1% to $20.5B Amid Innovation Surge
Stryker CorporationDescription
What this story covers
Stryker Corp's 2023 10-K reveals 20 point 5 billion dollars net sales, up 11 point 1 percent driven by volumes, with MedSurg/Neuro at 58 percent and Ortho/Spine at 42 percent. Gross margins rose to 63 point 7 percent, operating income to 19 percent. Strong liquidity with 3 point 7 billion dollars operating cash supports acquisitions like Cerus. Risks include regulations, supply chains, and geopolitics. Adjusted EPS hit 10 dollars 60 cents, positioning for growth.
Story snapshot
CompanyStryker Corporation
TickerSYK
VariantStandard detailed
Duration20:47
Filing type10-K
PeriodAnnual 2023
IndustryHealthcare & Pharmaceuticals
Accession0000310764-24-000024
Full Story Script
Content not available for this story.